{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:10:47Z","timestamp":1793621447344,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.diabet.2017.10.014","type":"journal-article","created":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T03:15:40Z","timestamp":1510370140000},"page":"4-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"title":["Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6994-8092","authenticated-orcid":false,"given":"S.","family":"Feldman-Billard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9.","family":"Larger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Massin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2017.10.014_bib0400","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2017.10.014_bib0405","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0410","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0415","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type\u00a02 diabetes (UKPDS\u00a033)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2017.10.014_bib0420","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type\u00a02 diabetes","volume":"363","author":"ACCORD study group","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0425","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2337\/diacare.7.3.236","article-title":"Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion","volume":"7","author":"van Ballegooie","year":"1984","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2017.10.014_bib0430","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(83)92585-0","article-title":"Effect of 1\u00a0year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics","volume":"1","author":"Lauritzen","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2017.10.014_bib0435","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/bmj.290.6471.811","article-title":"Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study","volume":"290","author":"Dahl-J\u00f8rgensen","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.diabet.2017.10.014_bib0440","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM198408093110604","article-title":"Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial","volume":"311","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0445","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archopht.116.7.874","article-title":"Early worsening of diabetic retinopathy in the diabetes control and complications trial","volume":"116","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.diabet.2017.10.014_bib0450","first-page":"774","article-title":"Standards for screening and surveillance of ocular complications in people with diabetes \u2013 2016","volume":"10","author":"Massin","year":"2016","journal-title":"Med Mal Metabol"},{"key":"10.1016\/j.diabet.2017.10.014_bib0455","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc16-2641","article-title":"Diabetic retinopathy: a position statement by the American Diabetes Association","volume":"40","author":"Solomon","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2017.10.014_bib0460","series-title":"Management of diabetic retinopathy. Clinical practice guidelines","year":"2008"},{"key":"10.1016\/j.diabet.2017.10.014_bib0465","series-title":"The Royal College of Physicians, The Royal College of Nursing. Diabetic retinopathy guidelines","year":"2012"},{"key":"10.1016\/j.diabet.2017.10.014_bib0470","unstructured":"American academy of ophthalmology, diabetic retinopathy. Preferred practice pattern. https:\/\/www.aao.org\/preferred-practice-pattern\/diabetic-retinopathy-ppp-updated-2016."},{"issue":"Suppl. 3","key":"10.1016\/j.diabet.2017.10.014_bib0475","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2337\/diab.34.3.S74","article-title":"Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy","volume":"34","author":"Lauritzen","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2017.10.014_bib0480","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/0002-9394(85)90618-X","article-title":"Effects of intensified insulin treatment on various lesions of diabetic retinopathy","volume":"100","author":"Brinchmann-Hansen","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.diabet.2017.10.014_bib0485","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bmj.304.6818.19","article-title":"Blood glucose concentrations and progression of diabetic retinopathy: the 7-year results of the Oslo study","volume":"304","author":"Brinchmann Hansen","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.diabet.2017.10.014_bib0490","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM199307293290502","article-title":"The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus","volume":"329","author":"Reichard","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0495","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s001250050602","article-title":"Complications in IDDM are caused by elevated blood glucose level: the Stockholm diabetes intervention study (SDIS) at 10-year follow-up","volume":"39","author":"Reichard","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2017.10.014_bib0500","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/aos.13066","article-title":"Retinal characteristics during 1\u00a0year of insulin pump therapy in type\u00a01 diabetes: a prospective, controlled, observational study","volume":"94","author":"Klefter","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.diabet.2017.10.014_bib0505","first-page":"CD009122","article-title":"Intensive glucose control versus conventional glucose control for type\u00a01 diabetes mellitus","volume":"2","author":"Fullerton","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.diabet.2017.10.014_bib0510","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ajo.2015.07.024","article-title":"Interventions for diabetic retinopathy in type\u00a01 diabetes: systematic review and meta-analysis","volume":"160","author":"Virk","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.diabet.2017.10.014_bib0515","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1046\/j.1464-5491.2001.00458.x","article-title":"Relationship between the severity of retinopathy and progression to photocoagulation in patients with type\u00a02 diabetes mellitus in the UKPDS (UKPDS\u00a052)","volume":"18","author":"Kohner","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0520","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s001250051594","article-title":"UKPDS\u00a050: risk factors for incidence and progression of retinopathy in type\u00a0II diabetes over 6\u00a0years from diagnosis","volume":"44","author":"Stratton","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2017.10.014_bib0525","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00125-009-1457-x","article-title":"Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type\u00a02 diabetes mellitus: a randomised controlled trial","volume":"52","author":"Beulens","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2017.10.014_bib0530","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ophtha.2014.07.019","article-title":"The effects of medical management on the progression of diabetic retinopathy in persons with type\u00a02 diabetes: the Action to control cardiovascular risk in diabetes (ACCORD) eye study","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.diabet.2017.10.014_bib0535","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s00125-014-3199-7","article-title":"Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the Veterans affairs diabetes trial (VADT)","volume":"57","author":"Azad","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2017.10.014_bib0540","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type\u00a02 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabet.2017.10.014_bib0545","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2337\/diacare.22.12.1944","article-title":"Progression of retinopathy after improved metabolic control in type\u00a02 diabetic patients","volume":"22","author":"Henricsson","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2017.10.014_bib0550","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/diacare.25.2.381","article-title":"Progression of retinopathy in insulin-treated type\u00a02 diabetic patients","volume":"25","author":"Henricsson","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2017.10.014_bib0555","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1096-9136(199702)14:2<123::AID-DIA306>3.0.CO;2-U","article-title":"The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus","volume":"14","author":"Henricsson","year":"1997","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0560","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1007\/s00125-004-1473-9","article-title":"Long-term progression of retinopathy after initiation of insulin therapy in type\u00a02 diabetes: an observational study","volume":"47","author":"Arun","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2017.10.014_bib0565","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.diabres.2013.03.018","article-title":"Euglycemic progression: worsening of diabetic retinopathy in poorly controlled type\u00a02 diabetes in minorities","volume":"100","author":"Shurter","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabet.2017.10.014_bib0570","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1056\/NEJM198801283180403","article-title":"Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus","volume":"318","author":"Ramsay","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0575","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1034\/j.1399-0012.1999.130413.x","article-title":"Diabetic retinopathy after combined kidney-pancreas transplantation","volume":"13","author":"Chow","year":"1999","journal-title":"Clin Transplant."},{"key":"10.1016\/j.diabet.2017.10.014_bib0580","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s00125-006-0463-5","article-title":"Pancreas transplant alone has beneficial effects on retinopathy in type\u00a01 diabetic patients","volume":"49","author":"Giannarelli","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2017.10.014_bib0585","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/TP.0b013e318172ca07","article-title":"Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy","volume":"85","author":"Thompson","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.diabet.2017.10.014_bib0590","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/TP.0b013e31820437f3","article-title":"Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy","volume":"91","author":"Thompson","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.diabet.2017.10.014_bib0595","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa1401329","article-title":"Bariatric surgery versus intensive medical therapy for diabetes \u2013 3-year outcomes","volume":"370","author":"Schauer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0600","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11695-012-0600-9","article-title":"Bariatric surgery and diabetic retinopathy: a pilot analysis","volume":"22","author":"Varadhan","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/j.diabet.2017.10.014_bib0605","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2337\/dc16-0157","article-title":"Clinical outcomes of metabolic surgery: microvascular and macrovascular complications","volume":"39","author":"Adams","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2017.10.014_bib0610","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00125-015-3595-7","article-title":"Type\u00a02 diabetes mellitus and microvascular complications 1\u00a0year after Roux-en-Y gastric bypass: a case-control study","volume":"58","author":"Miras","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2017.10.014_bib0615","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.2337\/dc14-2035","article-title":"Effect of bariatric surgery versus intensive medical management on diabetic ophthalmic outcomes","volume":"38","author":"Singh","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2017.10.014_bib0620","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2337\/dc16-0194","article-title":"Long-term microvascular disease outcomes in patients with type\u00a02 diabetes after bariatric surgery: evidence for the legacy effect of surgery","volume":"39","author":"Coleman","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2017.10.014_bib0625","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s11695-014-1539-9","article-title":"The impact of bariatric surgery on diabetic retinopathy: a systematic review and meta-analysis","volume":"25","author":"Cheung","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/j.diabet.2017.10.014_bib0630","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/dme.12727","article-title":"Progression of diabetic retinopathy after bariatric surgery","volume":"32","author":"Murphy","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0635","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1007\/s11695-015-1936-8","article-title":"Monitoring of diabetic retinopathy in relation to bariatric surgery: a prospective observational study","volume":"26","author":"Brynskov","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.diabet.2017.10.014_bib0640","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jdiacomp.2013.10.006","article-title":"Does bariatric surgery adversely impact on diabetic retinopathy in persons with morbid obesity and type\u00a02 diabetes? A pilot study","volume":"28","author":"Thomas","year":"2014","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabet.2017.10.014_bib0645","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.soard.2015.08.508","article-title":"The impact of bariatric surgery on retinopathy in patients with type\u00a02 diabetes: a retrospective cohort study","volume":"12","author":"Amin","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.diabet.2017.10.014_bib0650","doi-asserted-by":"crossref","DOI":"10.1038\/eye.2017.119","article-title":"Does bariatric surgery prevent progression of diabetic retinopathy?","author":"Chen","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.diabet.2017.10.014_bib0655","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/obr.12490","article-title":"Bariatric surgery and diabetic retinopathy: a systematic review and meta-analysis of controlled clinical studies","volume":"18","author":"Merlotti","year":"2017","journal-title":"Obes Rev"},{"key":"10.1016\/j.diabet.2017.10.014_bib0660","doi-asserted-by":"crossref","first-page":"354","DOI":"10.4093\/dmj.2016.40.5.354","article-title":"The effect of bariatric surgery on diabetic retinopathy: good, bad, or both?","volume":"40","author":"Gorman","year":"2016","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.diabet.2017.10.014_bib0665","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2337\/dc08-0864","article-title":"A1C variability and the risk of microvascular complications in type\u00a01 diabetes: data from the Diabetes control and complications trial","volume":"31","author":"Kilpatrick","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2017.10.014_bib0670","doi-asserted-by":"crossref","first-page":"e91137","DOI":"10.1371\/journal.pone.0091137","article-title":"HbA1c variability as an independent risk factor for diabetic retinopathy in type\u00a01 diabetes: a German\/Austrian multicenter analysis on 35,891\u00a0patients","volume":"9","author":"Hermann","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.diabet.2017.10.014_bib0675","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00125-012-2816-6","article-title":"HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type\u00a01 diabetes","volume":"56","author":"Hietala","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2017.10.014_bib0680","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1210\/jc.2015-3604","article-title":"Association between HbA1c variability and risk of microvascular complications in adolescents with type\u00a01 diabetes","volume":"101","author":"Virk","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2017.10.014_bib0685","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type\u00a02 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0690","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type\u00a02 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0695","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/brain\/awu307","article-title":"Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes","volume":"138","author":"Gibbons","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.diabet.2017.10.014_bib0700","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(97)06234-X","article-title":"Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. Diabetes audit and research in Tayside Scotland. Medicines monitoring unit","volume":"350","author":"Morris","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2017.10.014_bib0705","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI200317455","article-title":"Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization","volume":"111","author":"Kondo","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabet.2017.10.014_bib0710","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9440(10)63311-1","article-title":"Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy","volume":"165","author":"Poulaki","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.diabet.2017.10.014_bib0715","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1172\/JCI19478","article-title":"Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease","volume":"113","author":"Ruberte","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabet.2017.10.014_bib0720","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ghir.2010.12.001","article-title":"Pregnancy induced increase in circulating IGF-I is associated with progression of diabetic retinopathy in women with type\u00a01 diabetes","volume":"21","author":"Ringholm","year":"2011","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.diabet.2017.10.014_bib0725","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2362.2011.02616.x","article-title":"Interaction between glycaemic control and serum insulin-like growth factor\u00a01 on the risk of retinopathy in type\u00a02 diabetes","volume":"42","author":"Chen","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.diabet.2017.10.014_bib0730","first-page":"245","article-title":"Insulin therapy and GH-IGF-I axis disorders in diabetes: impact of glycaemic control and hepatic insulinization","volume":"22","author":"Hanaire-Broutin","year":"1996","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2017.10.014_bib0735","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s001250050604","article-title":"Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM","volume":"39","author":"Hanaire-Broutin","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2017.10.014_bib0740","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/S0161-6420(01)00853-3","article-title":"The effect of a growth hormone receptor antagonist drug on proliferative diabetic retinopathy","volume":"108","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.diabet.2017.10.014_bib0745","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1517\/13543784.16.1.73","article-title":"Medical treatment of diabetic retinopathy with somatostatin analogues","volume":"16","author":"Palii","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.diabet.2017.10.014_bib0750","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2017.10.014_bib0755","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11892-016-0825-4","article-title":"Vascular endothelial growth factor inhibitors for diabetic retinopathy","volume":"16","author":"Dhoot","year":"2016","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.diabet.2017.10.014_bib0760","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.diabet.2017.10.014_bib0765","doi-asserted-by":"crossref","first-page":"27975","DOI":"10.1074\/jbc.M204152200","article-title":"Insulin stimulates hypoxia-inducible factor\u00a01 through a phosphatidylinositol 3-kinase\/target of rapamycin-dependent signaling pathway","volume":"277","author":"Treins","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabet.2017.10.014_bib0770","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2337\/dc13-2002","article-title":"Ocular anti-VEGF therapy for diabetic retinopathy: the role of VEGF in the pathogenesis of diabetic retinopathy","volume":"37","author":"Simo","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2017.10.014_bib0775","doi-asserted-by":"crossref","first-page":"13505","DOI":"10.1073\/pnas.0906670106","article-title":"The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues","volume":"106","author":"Thangarajah","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"10.1016\/j.diabet.2017.10.014_bib0780","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","volume":"2","author":"Duh Ej","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.diabet.2017.10.014_bib0785","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/jcb.25283","article-title":"Hypoxia-inducible factor-1: a critical player in the survival strategy of stressed cells","volume":"117","author":"Chen","year":"2016","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.diabet.2017.10.014_bib0790","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11892-012-0289-0","article-title":"Novel targets against retinal angiogenesis in diabetic retinopathy","volume":"12","author":"Wang","year":"2012","journal-title":"Curr Diab Rep"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363617305700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363617305700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T12:19:13Z","timestamp":1535113153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363617305700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1262363617305700"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2017.10.014","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2017.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}